These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 11078612
1. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Werther K, Christensen IJ, Brünner N, Nielsen HJ. Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612 [Abstract] [Full Text] [Related]
2. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer. Oehler MK, Caffier H. Anticancer Res; 2000 Nov; 20(6D):5109-12. PubMed ID: 11326678 [Abstract] [Full Text] [Related]
3. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group. Eur J Surg; 2001 Apr; 167(4):287-92. PubMed ID: 11354321 [Abstract] [Full Text] [Related]
4. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H. Anticancer Res; 2002 Apr; 22(4):2437-42. PubMed ID: 12174940 [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G. Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991 [Abstract] [Full Text] [Related]
6. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group. Br J Cancer; 2002 Feb 01; 86(3):417-23. PubMed ID: 11875709 [Abstract] [Full Text] [Related]
7. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [Abstract] [Full Text] [Related]
8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB. J Pathol; 2003 Jun 01; 200(2):183-94. PubMed ID: 12754739 [Abstract] [Full Text] [Related]
11. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG. Cancer Res; 2001 Jul 15; 61(14):5407-14. PubMed ID: 11454684 [Abstract] [Full Text] [Related]
12. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. De Vita F, Orditura M, Lieto E, Infusino S, Morgillo F, Martinelli E, Castellano P, Romano C, Ciardiello F, Catalano G, Pignatelli C, Galizia G. Cancer; 2004 Jan 15; 100(2):270-8. PubMed ID: 14716760 [Abstract] [Full Text] [Related]
18. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Salven P, Orpana A, Joensuu H. Clin Cancer Res; 1999 Mar 15; 5(3):487-91. PubMed ID: 10100697 [Abstract] [Full Text] [Related]